This announcement is a separate document:
中 关 村：关于下属公司北京华素盐酸纳曲酮片一致性评价申报收到国家药品监督管理局《受理通知书》的公告
Zhongguancun: Notice regarding the receipt of the “Notice of Acceptance” from the China Drug Administration on the consistency evaluation application of Beijing Huasu hydrochloride naltrexone tablets by a subsidiary company
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.